498.06 USD
↗ 4.44 (0.90%)LIVE (AS OF 12:07 PM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
Market: OPEN
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $498.06. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$497.08
High?$503.37
Low?$478.53
Prev. Close?$493.62
Volume?156.8K
Avg. Volume?226.0K
VWAP?$487.44
Rel. Volume?0.69x
Bid / Ask
Bid?$498.18 × 40
Ask?$503.12 × 40
Spread?$4.94
Midpoint?$500.65
Valuation & Ratios
Market Cap?11.4B
Shares Out?23.1M
Float?16.5M
Float %?71.7%
P/E Ratio?N/A
P/B Ratio?21.78
EPS?-$14.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?62
Short Sent.?28
Piotroski F-Score?1/9Weak
Altman Z-Score?7.94Safe
Confidence?58%Low
Short InterestVery High
Short % of Float?13.64%High
Short Interest?2.3M
Days to Cover?11.4
Free Float16.5M
Avg Daily Volume197.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.20Strong
Quick Ratio?2.94Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.65Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?21.78HIGH▾
Peers100
S&P6
P/S?8.88HIGH▾
Peers100
S&P10
P/FCF?N/A▾
EV/EBITDA?-35.7CHEAP▾
S&P97
EV/Sales?8.92HIGH▾
Peers100
S&P14
Returns & Efficiency
ROE?-62.1%WEAK▾
S&P3
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-206285000
Enterprise Value?$11.5B
Fundamentals ratios updated end of day